Chapter II. 8 – Biocompatibility of Tissue Engineered Implants
暂无分享,去创建一个
[1] K. B. Hellman. Bioartificial Organs as Outcomes of Tissue Engineering Scientific and Regulatory Issues , 1997, Annals of the New York Academy of Sciences.
[2] M. Chapekar. Regulatory concerns in the development of biologic-biomaterial combinations. United States Food and Drug Administration. , 1996, Journal of biomedical materials research.
[3] C F Fox,et al. Prospects for application of biotechnology‐derived biomaterials , 1994, Journal of cellular biochemistry.
[4] Kiki B. Hellman,et al. Biomaterials and Biotechnology , 1993, Bio/Technology.
[5] James M. Anderson,et al. Perspectives on In Vivo Testing of Biomaterials, Prostheses, and Artificial Organs , 1988 .
[6] Tom Barnett,et al. Aami Standards and Recommended Practices , 1985 .
[7] Kiki B. Hellman,et al. Biomedical applications of tissue engineering technology: regulatory issues. , 1995, Tissue engineering.
[8] Lawrence J. Fogel,et al. Progress in Biomedical Engineering , 1967 .